Generic Medicine Info
Indications and Dosage
Peripheral vascular disease
Adult: 120 mcg/day in 3 divided doses.

Primary pulmonary hypertension
Adult: Initially, 60 mcg daily, given in 3 divided doses, may increase to 180 mcg daily, given in 3-4 divided doses if necessary.
Should be taken with food.
Patients with haemorrhage. Pregnancy.
Special Precautions
Patients on anticoagulants, antiplatelet or fibrinolytic agents. Menstruating women, patients with bleeding tendency or diathesis. May enhance bleeding tendency.
Adverse Reactions
Headache, hot flushes, GI upset, bleeding tendency, dizziness. Increased liver enzymes, triglycerides and bilirubin.
Drug Interactions
Anticoagulants, antiplatelet, fibrinolytic agents or any product that intensifies bleeding tendency. Prostaglandin I2 preparations.
Description: Beraprost is a synthetic analog of epoprostenol (a prostaglandin) which causes vasodilatation and prevents platelet aggregation.
MIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics) / Peripheral Vasodilators & Cerebral Activators
Disclaimer: This information is independently developed by MIMS based on Beraprost from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in